Document 0435
 DOCN  M9440435
 TI    Measles, mumps and rubella immunisation in children at risk of infection
       with human immunodeficiency virus.
 DT    9404
 AU    Molyneaux PJ; Mok JY; Burns SM; Yap PL; Regional Virus Laboratory, City
       Hospital, Edinburgh, U.K.
 SO    J Infect. 1993 Nov;27(3):251-3. Unique Identifier : AIDSLINE
       MED/94141242
 AB    A retrospective serological study of 81 children at risk of HIV (II
       HIV-infected, 70 HIV-negative) was performed to assess susceptibility to
       measles, mumps and rubella and response to measles, mumps and rubella
       (MMR) immunisation. There was no difference in the initial serological
       response between the HIV-infected and HIV-negative children. Repeat
       serology should be performed on HIV-infected children as during
       follow-up antibodies may be lost. Reimmunisation should be considered
       for the seronegative.
 DE    Antibodies, Viral/*BLOOD  Comparative Study  Drug Combinations  Human
       HIV Infections/*IMMUNOLOGY  HIV Seropositivity  Infant  Infant, Newborn
       Measles/PREVENTION & CONTROL  Measles Vaccine/*IMMUNOLOGY  Measles
       Virus/IMMUNOLOGY  Mumps/PREVENTION & CONTROL  Mumps Vaccine/*IMMUNOLOGY
       Mumps Virus/IMMUNOLOGY  Prospective Studies  Risk Factors
       Rubella/PREVENTION & CONTROL  Rubella Vaccine/*IMMUNOLOGY  Rubella
       Virus/IMMUNOLOGY  *Vaccination  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).